Pharma companies are facing pricing pressure from several directions, including from the U. S. Medicare negotiations.
pharmaceutical
30 years after Upjohn merger, Kalamazoo area proves its resilience
As Trumponomics continues to fail and Mamdani rediscovers that rent control doesn’t work, there will come a...
Photo credits: zverge / BigStock The Novo Nordisk Foundation in Denmark, one of the world’s leading funders...
Evening Reading - October 28, 2025
